1.
KA Kreuzer, P le Coutre. Re: Lange T et al. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. Leukemia 2004; 89: 49-57. haematol [Internet]. 2004Aug.1 [cited 2024Jul.22];89(8):ELT12-ELT12. Available from: https://haematologica.org/article/view/3208